Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies

The Lancet Diabetes and Endocrinology

Volumn 6, Issue 7, 2018, Pages 538-546

  Gnatiuc, L ^a   Herrington, W G ^a   Halsey, J ^a   Tuomilehto, J ^a   Fang, X ^a   Kim, H C ^a   De Bacquer, D ^a   Dobson, A J ^a   Criqui, M H ^a   Jacobs, D R ^a   Leon, D A ^a   Peters, S A E ^a   Ueshima, H ^a,a   Sherliker, P ^a   Peto, R ^a   Collins, R ^a   Huxley, R R ^a   Emberson, J R ^a   Woodward, M ^a   Lewington, S ^a   Aoki, N ^a   Arima, H ^a   Arnesen, E ^a   Aromaa, A ^a   Assmann, G ^a   Bachman, D L ^a   Baigent, C ^a   Bartholomew, H ^a   Benetos, A ^a   Bengtsson, C ^a   Bennett, D ^a   Bjorkelund C ^a   Blackburn, H ^a   Bonaa, K ^a   Boyle, E ^a   Broadhurst, R ^a   Carstensen, J ^a   Chambless, L ^a   Chen, Z ^a   Chew, S K ^a   Clarke, R ^a   Cox, C ^a   Curb, J D ^a   D'Agostino, R ^a   Date, C ^a   Davey Smith, G ^a   De Backer, G ^a   Dhaliwal, S S ^a   Duan, X F ^a   Ducimetiere, P ^a   Duffy, S ^a   Eliassen, H ^a   Elwood, P ^a   Empana, J ^a   Garcia Palmieri, M H ^a   Gazes, P ^a   Giles, G G ^a   Gillis, C ^a   Goldbourt, U ^a   Gu, D F ^a   Guasch Ferre, M ^a   Guize, L ^a   Haheim, L ^a   Hart, C ^a   Hashimoto, S ^a   Hashimoto, T ^a   Heng, D ^a   Hjermann, I ^a   Ho, S C ^a   Hobbs, M ^a   Hole, D ^a   Holme, I ^a   Horibe, H ^a   Hozawa, A ^a   Hu, F ^a   Hughes, K ^a   Iida, M ^a   Imai, K ^a   Imai, Y ^a   Iso, H ^a   Jackson, R ^a   Jamrozik, K ^a   Jee, S H ^a   Jensen, G ^a   Jiang, C Q ^a   Johansen, N B ^a   Jorgensen, T ^a   Jousilahti, P ^a   Kagaya, M ^a   Keil, J ^a   Keller, J ^a   Kim, I S ^a   Kita, Y ^a   Kitamura, A ^a   Kiyohara, Y ^a   Knekt, P ^a   Knuiman, M ^a   Kornitzer, M ^a   Kromhout, D ^a   Kronmal, R ^a   Lam, T H ^a   Law, M ^a   Lee, J ^a   Leren, P ^a   Levy, D ^a   Li, Y H ^a   Lissner, L ^a   Luepker, R ^a   Luszcz, M ^a   MacMahon, S ^a   Maegawa, H ^a   Marmot, M ^a   Matsutani, Y ^a   Meade, T ^a   Morris, J ^a   Morris, R ^a   Murayama, T ^a   Naito, Y ^a   Nakachi, K ^a   Nakamura, M ^a   Nakayama, T ^a   Neaton, J ^a   Nietert, P J ^a   Nishimoto, Y ^a   Norton, R ^a   Nozaki, A ^a   Ohkubo, T ^a   Okayama, A ^a   Pan, W H ^a   Puska, P ^a   Qizilbash, N ^a   Reunanen, A ^a   Rimm, E ^a   Rodgers, A ^a   Saitoh, S ^a   Sakata, K ^a   Sato, S ^a   Schnohr, P ^a   Schulte, H ^a   Selmer, R ^a   Sharp, D ^a   Shifu, X ^a   Shimamoto, K ^a   Shipley, M ^a   Silbershatz, H ^a   Sorlie, P ^a   Sritara, P ^a   Suh, I ^a   Sutherland, S E ^a   Sweetnam, P ^a   Tamakoshi, A ^a   Tanaka, H ^a   Thomsen, T ^a   Tominaga, S ^a   Tomita, M ^a   Tornberg S ^a   Tunstall Pedoe, H ^a   Tverdal, A ^a   Vartiainen, E ^a   Wald, N ^a   Wannamethee, S G ^a   Welborn, T A ^a   Whincup, P ^a   Whitlock, G ^a   Willett, W ^a   Woo, J ^a   Wu, Z L ^a   Yao, S X ^a   Yarnell, J ^a   Yokoyama, T ^a   Yoshiike, N ^a   Zhang, X H ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

AGE DISTRIBUTION; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD VESSEL OCCLUSION; BODY HEIGHT; BODY MASS; BODY WEIGHT; BRAIN ISCHEMIA; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; MORTALITY RATE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTEMATIC REVIEW; TOBACCO USE; ADULT; AGED; CARDIOVASCULAR DISEASE; COMPLICATION; DIABETIC COMPLICATION; FEMALE; MALE; META ANALYSIS; MIDDLE AGED; PROSPECTIVE STUDY; SEX FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 85046724201     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(18)30079-2     Document Type: Article

References (35)

1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet 387 (2016), 1513–1530.
2. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364 (2011), 829–841.
3. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375 (2010), 2215–2222.
4. Bragg, F, Holmes, MV, Iona, A, et al. Association between diabetes and cause-specific mortality in rural and urban areas of China. JAMA 317 (2017), 280–289.
5. Alegre-Díaz, J, Herrington, W, López-Cervantes, M, et al. Diabetes and cause-specific mortality in Mexico City. N Engl J Med 375 (2016), 1961–1971.
6. Prospective Studies Collaboration. Collaborative overview (‘meta-analysis’) of prospective observational studies of the associations of usual blood pressure and usual cholesterol levels with common causes of death: protocol for the second cycle of the Prospective Studies Collaboration. J Cardiovasc Risk 6 (1999), 315–320.
7. Woodward, M, Barzi, F, Martiniuk, A, et al. Cohort profile: the Asia Pacific Cohort Studies Collaboration. Int J Epidemiol 35 (2006), 1412–1416.
8. Carey, VJ, Walters, EE, Colditz, GA, et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 145 (1997), 614–619.
9. Rimm, EB, Stampfer, MJ, Colditz, GA, Chute, CG, Litin, LB, Willett, WC, Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1 (1990), 466–473.
10. WHO. International statistical classification of diseases and related health problems: tenth revision (ICD-10). 2nd edn., vol 2, 2004, World Health Organization, Geneva.
11. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002), 1903–1913.
12. Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet 370 (2007), 1829–1839.
13. Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373 (2009), 1083–1096.
14. Plummer, M, Improved estimates of floating absolute risk. Stat Med 23 (2004), 93–104.
15. Peters, SAE, Huxley, RR, Woodward, M, Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes. Lancet 383 (2014), 1973–1980.
16. Shah, AD, Langenberg, C, Rapsomaniki, E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Lancet Diabetes Endocrinol 3 (2015), 105–113.
17. Gouni-Berthold, I, Berthold, HK, Mantzoros, CS, Bohm, M, Krone, W, Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care 31 (2008), 1389–1391.
18. Turnbull, F, Woodward, M, Neal, B, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J 29 (2008), 2669–2680.
19. Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials. Lancet 385 (2015), 1397–1405.
20. Woodward, M, Peters, SA, Huxley, RR, Diabetes and the female disadvantage. Womens Health (Lond) 11 (2015), 833–839.
21. Rossouw, JE, Anderson, GL, Prentice, RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002), 321–333.
22. Kautzky-Willer, A, Harreiter, J, Pacini, G, Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev 37 (2016), 278–316.
23. Parish, S, Offer, A, Clarke, R, et al. Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study. Circulation 125 (2012), 2469–2478.
24. Parish, S, Peto, R, Palmer, A, et al. The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls. Eur Heart J 30 (2009), 2137–2146.
25. Regensteiner, JG, Golden, S, Huebschmann, AG, et al. Sex differences in the cardiovascular consequences of diabetes mellitus: a scientific statement from the American Heart Association. Circulation 132 (2015), 2424–2447.
26. Wannamethee, SG, Papacosta, O, Lawlor, DA, et al. Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia 55 (2012), 80–87.
27. Ridker, PM, Everett, BM, Thuren, T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377 (2017), 1119–1131.
28. Herrington, W, Alegre-Diaz, J, Wade, R, et al. Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study. Lancet Diabetes Endocrinol, 2018 published online March 19. DOI:10.1016/S2213-8587(18)30050-0.
29. Tancredi, M, Rosengren, A, Svensson, AM, et al. Excess mortality among persons with type 2 diabetes. N Engl J Med 373 (2015), 1720–1732.
30. Matuleviciene-Anängen, V, Rosengren, A, Svensson, AM, et al. Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes. Heart 103 (2017), 1687–1695.
31. Tuomilehto, J, The emerging global epidemic of type 1 diabetes. Curr Diab Rep 13 (2013), 795–804.
32. WHO. Global action plan for the prevention and control of non-communicable diseases 2013–2020. 2013, World Health Organization, Geneva http://www.who.int/nmh/events/ncd_action_plan/en/. (Accessed 28 September 2017)
33. Emdin, CA, Rahimi, K, Neal, B, Callender, T, Perkovic, V, Patel, A, Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA 313 (2015), 603–615.
34. Xie, X, Atkins, E, Lv, J, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet 387 (2016), 435–443.
35. Stone, NJ, Robinson, JG, Lichtenstein, AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129:suppl 2 (2014), S1–S45.